Today's health news spans psychiatric medication comparisons for stroke patients, critical NHS staffing shortages threatening care quality, FDA breast cancer drug approvals, and mixed results in genetic disease and surgical treatment trials.

Bupropion shows lower suicidal ideation risk compared to fluoxetine in post-stroke depression treatment, but is associated with higher rates of demoralization and apathy, according to new research comparing these two antidepressant classes.

One quarter of nurses report dangerously inadequate staffing levels on their last shift, creating high-risk conditions for both patient and staff safety, according to an RCN Congress survey.

The FDA has expanded approval for trastuzumab deruxtecan (T-DXd) to cover both neoadjuvant and adjuvant settings in HER2-positive early-stage breast cancer treatment.

Two-thirds of NHS trust and ICB leaders anticipate service cuts in 2026, with 90% expressing concerns about the impact on staff morale amid funding pressures.

New York City's 'Mold Busters' program in public housing is associated with reduced emergency department asthma visits, though effectiveness varies by building characteristics including age and size.

BioMarin Pharmaceutical's experimental genetic disease therapy achieved one of two primary endpoints in late-stage clinical trials, showing mixed results for the rare condition treatment.

Research suggests concurrent radiation dose escalation to the lumpectomy cavity during whole-breast irradiation may safely shorten overall breast cancer radiation treatment compared to sequential boost approaches.

A randomized trial found that omitting extended antibiotics following cystectomy does not increase urinary tract infection risk, potentially eliminating unnecessary post-surgical antibiotic use.